Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank7
3Y CAGR-77.9%
5Y CAGR-21.7%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-77.9%/yr
vs +114.3%/yr prior
5Y CAGR
-21.7%/yr
Recent deceleration
Acceleration
-192.2pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$568000.00-7.8%
2024$616000.00-99.0%
2023$58.97M+12.3%
2022$52.52M-4.6%
2021$55.05M+2753.6%
2020$1.93M-40.3%
2019$3.23M+29.7%
2018$2.49M+31.2%
2017$1.90M-98.8%
2016$163.97M-